Sponsor pipeline

Madrigal Pharmaceuticals, Inc. clinical trial pipeline

Get alerts when Madrigal Pharmaceuticals, Inc.'s trials change

8 active trials 3 recruiting 3 Phase 3 2 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-09-12
Recruitment opened
NCT07763015 Study of Resmetirom in Children and Adolescents With MASH · Phase 2

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-29 NCT07848191 Rezdiffra® With Concomitant Therapies Commonly Used to Treat Comorbidities in Adults With… Phase 4 Not Yet Recruiting
2026-09-21 NCT07830758 Resmetirom in Patients With MASH and HFpEF Phase 1 Not Yet Recruiting

Active trials by phase

Phase 1
1
Phase 2
2
Phase 3
3
Phase 4
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT07848191 Rezdiffra® With Concomitant Therapies Commonly Used to Treat Comorbidities in Adults With… MASH - Metabolic Dysfunction-Associated Steatohepatitis Not Yet Recruiting 2026-09-29
Phase 3
NCT05500222 A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients… NASH Active, Not Recruiting 2026-07-08
NCT03900429 A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients… NASH - Nonalcoholic Steatohepatitis Active, Not Recruiting 2026-06-01
NCT04951219 A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients… Non-Alcoholic Fatty Liver Disease Active, Not Recruiting 2026-05-27
Phase 2
NCT07763015 Study of Resmetirom in Children and Adolescents With MASH MASH Recruiting 2026-09-11
NCT07335601 Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH MASH - Metabolic Dysfunction-Associated Steatohepatitis Recruiting 2026-08-26
Phase 1
NCT07830758 Resmetirom in Patients With MASH and HFpEF MASH - Metabolic Dysfunction-Associated Steatohepatitis Not Yet Recruiting 2026-09-21
Not specified
NCT07541469 Rezdiffra Pregnancy and Lactation Registry MASH - Metabolic Dysfunction-Associated Steatohepatitis Recruiting 2026-04-21

Disease areas by active trials

NASH / MASH (8) · Heart Failure (1)

Get alerts when Madrigal Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free